Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 1,408

Document Document Title
WO/2017/057851A1
The present invention relates to a ginsenoside fatty acid ester compound, a method for preparing same, and a cosmetic composition comprising same and, more specifically, to a ginsenoside fatty acid ester compound, modified into a fatty a...  
WO/2017/057852A1
The present invention relates to a ginsenoside fatty acid ester compound, a method for preparing same, and a cosmetic composition comprising same and, more specifically, to a ginsenoside fatty acid ester compound, modified into a fatty a...  
WO/2017/044659A1
The present disclosure is directed to compositions, formulations and methods of use thereof in the treatment and prevention of ocular conditions including cataract and presbyopia.  
WO/2017/023694A1
This invention relates the use of Cortisol blockers (e.g., glucocorticoid receptor [GR] antagonists) for the treating or preventing viral infections, treating or preventing treatment resistant prostate cancer, treating or preventing neop...  
WO/2017/003124A1
The present invention relates to a method for screening a mitochondrial activity enhancer by using gypenoside-treated cells, to a composition, containing the gypenoside, for screening the mitochondrial activity enhancer, and to a kit com...  
WO/2016/164504A1
The invention provides bioconjugates of heterocylic compounds such as S-adenosylmethionine and S-adenosylhomocysteine with biotin or digoxigenin. The bioconjugates also include carbon and nitrogen linker moiteies of varying length that a...  
WO/2016/127543A1
Provided are a class of sucrose ester-type cationic lipoids and a preparation method therefor. A vector prepared by using the cationic lipoid can be used to deliver a nucleic acid. The sucrose ester-type cationic lipoid is prepared by us...  
WO/2016/107471A1
The present invention relates to a chemical and pharmaceutical technology, and in particular to a STAT3 and ERK signal pathway inhibitor and a use thereof. On the one hand, provided is a STAT3 and ERK signal pathway inhibitor. The inhibi...  
WO/2016/095249A1
Provided are a 20(R)-ginsenoside Rg3 multiacylated derivative, as represented by the formula (I), and a preparation method and antitumor application of same. R=CH3(CH2)nCO, and n=0 to 5.  
WO/2016/095248A1
The present invention provides a 20(R)-ginsenoside Rg3 derivative, as represented by the formula (I), and a preparation method and antitumor application of same. R1=H, R2=CnH2n+1CO or R1=CnH2n+1CO, R2=H or R1=R2=CnH2n+1CO, and n=3 to 30.  
WO/2016/090139A1
Described herein are compositions and methods for hormone replacement therapy that address the shortcomings of the existing methods. Described herein are pharmaceutically effective partial agonistic antiprogestins. The combined applicati...  
WO/2016/082789A1
Described herein are neuroactive steroids of the Formula (II) : or a pharmaceutically acceptable salt thereof; wherein A, R1, R2a, R2b, R3a, R3b, R4a, R4b, R5, R6 and ----- are as defined herein. Such compounds are envisioned, in certain...  
WO/2015/177469A1
The present invention relates to chemical compounds and the therapeutic use thereof, in particular for improving muscular quality in mammals. More particularly, the invention enables improvement of muscular quality in sarcopenic mammals ...  
WO/2015/168779A1
A method for purifying Mogroside V comprises passing a solution of a pre-prepared Siraitia grosvenori primary extract through a multi-column system including a plurality of columns, in series, packed with a porous adsorbent resin to prov...  
WO/2015/171555A1
Disclosed is a steviol glycoside referred to as rebaudioside D2. Rebaudioside D2 has five β-D-glucosyl units connected to the aglycone steviol. Also disclosed are methods for producing rebaudioside D2, a UDP-glycosyltransferase fusion e...  
WO/2015/081778A1
The present invention belongs to the field of organic synthesis, relates to a method for synthesizing a saponin, and in particular, to a method for constructing a glycosidic bond in a saponin, and comprises the following steps: directly ...  
WO/2015/082012A1
Suggested are triterpene-glycoside compounds, which are obtainable by the extraction of Momordica grosvenorii (Siraitia grosvenori) which are useful as a sweetener or sweetener enhancer in preparations and compositions, especially oral e...  
WO/2015/062556A1
Use of a composition comprising plant based saponins for regulating and balancing gut microflora in a subject.  
WO/2014/189351A3
The present invention describes a process to obtain the compound 6-0-palmitoyl-3-beta-D-glucopyranosyl-campesterol (6-O-PGC) from Lopezia racemosa extracts. The procedure to prepare extracts and fractions from Lopezia racemosa wild plant...  
WO/2014/146089A3
Novel mogrosides and methods for heir purification are provided herein. In addition, compositions comprising said novel mogrosides and methods for preparing the same are provided. The present invention relates generally to novel mogrosid...  
WO/2014/194068A1
Compounds which are glycosylates of an A-ring of a cardiotonic steroid, wherein the steroid is attached to the anomeric position of (a) a monosaccharide comprising a C-4 amino group, or (b) an oligosaccharide are provided.  
WO/2014/189351A2
The invention relates to the method for producing the compound 6-0-palmitoyl-3-0-β-P-D-glucopyranosyl-campesterol(6-O-PGC) with a novel structure and with in vivo anti-inflammatory activity, from plant extracts obtained from in vitro c...  
WO/2014/150127A1
Fruit extracts containing mogrol glycosides substituted with five or more sugar residues per molecule such as mogroside V may be treated with acid or enzymes to increase the content of mogrol glycosides such as siamenoside I and mogrosid...  
WO/2014/146089A2
Novel mogrosides and methods for heir purification are provided herein. In addition, compositions comprising said novel mogrosides and methods for preparing the same are provided.  
WO/2013/149570A1
Provided are several types of ginsenoside polymorphic substances and a method for preparing same. In particular, new crystal form A, crystal form B, crystal form C, crystal form E, crystal form F, crystal form I, crystal form K, crystal ...  
WO/2013/149571A1
Provided are ginsenoside C-K polymorphic forms and a method for preparing same. The ginsenoside C-K polymorphic forms are crystal form D and crystal form H.  
WO/2013/143494A1
Disclosed is a protopanaxatriol ginsenoside preparation method, comprising the following steps: (a) protecting the hydroxyl of the protopanaxatriol, exposing a 20-position hydroxyl and at least one of 3-position, 6-position and 12-positi...  
WO/2013/100712A1
The present invention relates to a novel blocker for vascular leakage. The novel blocker for vascular leakage of the present invention inhibits the apoptosis of endothelial cells, suppresses the formation of actin stress fibers induced b...  
WO/2013/040441A1
The invention relates to a drug conjugate including a drug and a plant steroid. The drug conjugate may target the drug for intestinal cell delivery, and thus may be used to treat diseases, including intestinal diseases, or to affect inte...  
WO/2012/127176A1
The present invention relates to novel neurosteroids, especially derivatives of allopregnanolone and of epiallopregnanolone of formula (I) and the uses thereof as medicament for the treatment of neuropathologies, in particular neuropathi...  
WO/2012/100018A1
Stabilized benzyl phosphonic acid and naphthyl phosphonic acid analog compounds are effective in inhibiting the activity of autotaxin.  
WO/2012/079275A1
Provided is a method for preparing fluticasone furoate (fluoromethyl 6α,9α-difluoro-11β-hydroxy-16a-methyl-17α-[(2-furoyl)oxy ]-3-one androsta-1,4-diene-17β-thiocarboxylate) represented by Formula I. The method comprises: 1) forming...  
WO/2012/068832A1
Provided is a method for preparing mogroside IV, which comprises hydrolyzing mogroside V, Momordica grosvenori fruits, or extracts of Momordica grosvenori fruits containing mogroside V with β-glucosidase. The content of mogroside IV in ...  
WO/2012/027957A1
Bufalin derivatives of formula I and the pharmaceutical compositions thereof are provided, wherein the radicals have the meanings as defined in the invention. The use of these derivatives is also provided.  
WO/2011/077800A1
A neutral fat level control agent, a cholesterol level control agent, a free fatty acid level control agent and an anti-obesity agent, each characterized by comprising at least one of protopanaxatriol, panaxatriol, protopanaxadiol and pa...  
WO/2011/073419A1
The present invention relates to a compound of formula (I) for its use for reversing or inhibiting multidrug resistance.  
WO/2011/036557A1
Compositions, methods and compounds useful for enhancing the uptake of a lipid particle b\ a cell are described In particular embodiments, the methods of the invention include contacting a cell with a lipid particle and a compound that b...  
WO/2011/010364A1
Disclosed is a novel compound having a neurite-outgrowing activity and is therefore useful for the prevention or treatment of neurodegenerative diseases. Specifically disclosed is a compound represented by formula (I) [wherein X represen...  
WO/2011/002033A1
A glucose metabolism-improving agent having an activity of suppressing the increase in an after-meal glucose level, an activity of decreasing a fasting glucose level, an activity of regulating a glucose metabolism-related measure in seru...  
WO/2010/088866A3
This invention relates to novel saponin compounds of formula II wherein MBz denotes p-methoxybenzoyl, and R is selected from the group comprising C6-10 aryl, C6-10 aryl-C1-4 alkyl-, C1-18 alkanoyl, C3-18 alkenoyl, C6-10 aryl-C(O)-, C6-10...  
WO/2010/048710A8
The invention relates to compositions for use in animal models of neurodegenerative disease and methods therefor. More particularly, the invention relates to the use of neurotoxic sterol glycosides or neurotoxic glycolipids, or combinati...  
WO/2010/102952A1
The present invention relates to a process of reducing the content of steryl glycoside in a bio-diesel composition which comprises a step of contacting the composition with an enzyme being capable of acylating the steryl glycoside.  
WO/2010/095741A1
Disclosed is a novel steroid derivative which is expected to exhibit an NGF activity. Specifically disclosed is a compound represented by formula (A) or (B). (In the formulae (A) and (B), n represents 1 or 2.)  
WO/2010/058794A1
Disclosed is a highly safe antioxidant which suppress oxidation of biological components, particularly oxidation of lipids, and can be used as a pharmaceutical product, food, drink, food additive, external preparation for the skin and th...  
WO/2010/048710A1
The invention relates to compositions for use in animal models of neurodegenerative disease and methods therefor. More particularly, the invention relates to the use of neurotoxic sterol glycosides or neurotoxic glycolipids, or combinati...  
WO/2010/004423A3
The present invention relates to a method for reducing the amount of steryl glycoside in an oil or fat (e.g. a biofuel substrate) and/or a biofuel, the method comprising admixing one or more enzymes with an oil or fat comprising steryl g...  
WO/2010/041681A1
Provided is a novel compound which is a sominone derivative represented by formula (1) or a salt thereof and which is useful as an agent for the prevention and treatment of neurological disease.  
WO/2010/029915A1
Disclosed is a simple method for producing a plant containing sapogenin, which contains a large quantity of sapogenin and has outstanding taste and safety, using a plant containing saponin as the raw material. The method for producing a ...  
WO/2010/027992A1
A method of preventing preeclampsia including administering to a patient during an early stage of pregnancy a prophylactically-effective amount of resibufogenin. The administration of resibufogenin is periodically repeated. The method se...  
WO/2009/106360A3
The present invention relates to a method for purifying biodiesel, biodiesel precursors, or the mixtures thereof, which contain at least one glycoside, wherein biodiesel or a biodiesel precursor or a mixture thereof is incubated with at ...  

Matches 51 - 100 out of 1,408